Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZocuFoam is an over-the-counter (OTC) topical eyelid cleanser and moisturizer developed by Zocular. It is formulated using the patented Zokrex platform, which features an activated okra complex (Hibiscus esculentus fruit extract) as its primary active component. The product utilizes micellar Zocusome technology to effectively remove debris, oils, and makeup from the eyelid margins and lashes. It is intended for eyelid hygiene and the management of symptoms associated with dry eye disease, blepharitis, and Demodex infestation. The okra-based polysaccharide complex provides natural anti-inflammatory, anti-microbial, and anti-oxidant properties, offering a gentle alternative to tea tree oil-based cleansers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ZocuFoam.